Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07468656
Eligibility Criteria:
Inclusion Criteria:
* Pathologically documented small cell lung cancer (SCLC) or neuroendocrine tumor
* Appropriate candidate for treatment with tarlatamab based on investigator discretion
* Age \> 18 years
* Signed written informed consent including HIPAA according to institutional guidelines
Exclusion Criteria:
* Does not meet all inclusion criteria
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07468656
Study Brief:
Protocol Section:
NCT07468656